Evidence map›Paper›PMID 15030681›Full record

ArticleEmerging infectious diseases2004

SARS surveillance during emergency public health response, United States, March-July 2003.

Stephanie J Schrag, John T Brooks, Chris Van Beneden, Umesh D Parashar, Patricia M Griffin, Larry J Anderson, William J Bellini, Robert F Benson, Dean D Erdman, Alexander Klimov and 27 more

Open access · diamondAbstract read
In one paragraph

Article in Emerging infectious diseases, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Review
  3. Molecular characterization and distinguishing features of a novel human rhinovirus (HRV) C, HRVC-QCE, detected in children with fever, cough and wheeze during 2003.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2010
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Prevalence of viral respiratory tract infections in children with asthma.The Journal of allergy and clinical immunology · 2007
    Article
  10. Early diagnosis of SARS: lessons from the Toronto SARS outbreak.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2006
    Article
  11. Can routine laboratory tests discriminate between severe acute respiratory syndrome and other causes of community-acquired pneumonia?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2005
    Article
  12. SARS clinical features, United States, 2003.Emerging infectious diseases · 2005
    Article
  13. Article
  14. Wrestling SARS from uncertainty.Emerging infectious diseases · 2004
    Article
  15. Review
  16. Article
  17. Was WHO SARS-related travel advisory for Toronto ethical?Canadian journal of public health = Revue canadienne de sante publique
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors at 1 institution in 1 country.

Stephanie J SchragDivision of Bacterial and Mycotic Diseases, Respiratory Diseases Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. zha6@cdc.gov
John T Brooks
Chris Van Beneden
Umesh D Parashar
Patricia M Griffin
Larry J Anderson
William J Bellini
Robert F Benson
Dean D Erdman
Alexander Klimov
Thomas G Ksiazek
Teresa C T Peret
Deborah F Talkington
W Lanier Thacker
Maria L Tondella
Jacquelyn S Sampson
Allen W Hightower
Dale F Nordenberg
Brian D Plikaytis
Ali S Khan
Nancy E Rosenstein
Tracee A Treadwell
Cynthia G Whitney
Anthony E Fiore
Tonji M Durant
Joseph F Perz
Annemarie Wasley
Daniel Feikin
Joy L Herndon
William A Bower
Barbara W Klibourn
Deborah A Levy
Victor G Coronado
Joanna Buffington
Clare A Dykewicz
Rima F Khabbaz
Mary E Chamberland
Centers for Disease Control and Prevention · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In response to the emergence of severe acute respiratory syndrome (SARS), the United States established national surveillance using a sensitive case definition incorporating clinical, epidemiologic, and laboratory criteria. Of 1,460 unexplained respiratory illnesses reported by state and local health departments to the Centers for Disease Control and Prevention from March 17 to July 30, 2003, a total of 398 (27%) met clinical and epidemiologic SARS case criteria. Of these, 72 (18%) were probable cases with radiographic evidence of pneumonia. Eight (2%) were laboratory-confirmed SARS-coronavirus (SARS-CoV) infections, 206 (52%) were SARS-CoV negative, and 184 (46%) had undetermined SARS-CoV status because of missing convalescent-phase serum specimens. Thirty-one percent (124/398) of case-patients were hospitalized; none died. Travel was the most common epidemiologic link (329/398, 83%), and mainland China was the affected area most commonly visited. One case of possible household transmission was reported, and no laboratory-confirmed infections occurred among healthcare workers. Successes and limitations of this emergency surveillance can guide preparations for future outbreaks of SARS or respiratory diseases of unknown etiology.

Indexed as

Disease OutbreaksAdolescentAdultAgedAged, 80 and overBase SequenceCenters for Disease Control and Prevention, U.S.ChildChild, PreschoolDiagnosis, DifferentialDNA, ViralEmergenciesFemaleHumansInfantMaleDNA, Viral

Identifiers

PMID15030681
PMCPMC3322912
OpenAlexW1976873281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.